Enter inventor name

Wayne R Godfrey

This inventor holds 14 USPTO granted patents and 2 EPO patents. Top assignees: Leland Stanford Junior University, University of Pennsylvania, Becton Dickinson and Company Limited. Active years: 1998-2016.

USPTO Granted Patents = 14

% Patents Active = 64.3

EPO Patents = 2

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 168(Granted Patents)

Location History:

White Bear Lake, MN (US) (2000)
Woodside, CA (US) (1998 - 2008)
Birchwood, MN (US) (2006 - 2010)
Los Altos, CA (US) (2012 - 2016)

Company Filing History:

8 out of 5,497

Leland Stanford Junior University

patents

5 out of 2,651

University of Pennsylvania

patents

2 out of 5,394

Becton Dickinson and Company Limited

patents

4. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2016

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9273282 - Methods for the isolation and expansion of cord blood derived T regulatory cells (2016-03-01),

2. 9187727 - Methods for the isolation and expansion of cord blood derived T regulatory cells (2015-11-17),

3. 9181526 - Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses (2015-11-10),

4. 8129185 - Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses (2012-03-06),

5. 7651855 - Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses (2010-01-26),

6. 7364733 - Antibody to receptor on the surface of activated T-cells: ACT-4 (2008-04-29),

7. 7125670 - [object Object] (2006-10-24),

8. 7098184 - Method of treating rheumatoid arthritis and multiple sclerosis diseases of the human immune system (2006-08-29),

9. 6528623 - Antibodies that specifically bind ACT-4-L-h-1 ligand (2003-03-04),

10. 6528055 - Methods of administering antibodies that specifically bind ACT-4-L-h-1 ligand (2003-03-04),

11. 6277962 - Receptor on the surface of activated t-cells: act-4 (2001-08-21),

12. 6242566 - Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells (2001-06-05),

13. 6156878 - Ligand (ACT-4-L) to a receptor on the surface of activated CD4.sup.+ (2000-12-05),

14. 5821332 - Receptor on the surface of activated CD4.sup.+ T-cells: ACT-4 (1998-10-13),

Title: Wayne R Godfrey: Innovator in Cord Blood Research

Introduction

Wayne R Godfrey is a prominent inventor based in Los Altos, CA (US). He has made significant contributions to the field of medical research, particularly in the area of cord blood-derived T regulatory cells. With a total of 14 patents to his name, Godfrey's work has the potential to impact therapeutic approaches in immunology.

Latest Patents

One of his latest patents is titled "Methods for the isolation and expansion of cord blood derived T regulatory cells." This invention encompasses methods and kits for the isolation and expansion of T regulatory cells that have the CD45RA phenotype, including such cells derived from human umbilical cord blood. This innovative approach aims to enhance the availability of these crucial cells for research and therapeutic applications.

Career Highlights

Throughout his career, Wayne R Godfrey has worked with esteemed institutions such as Leland Stanford Junior University and the University of Pennsylvania. His research has focused on advancing the understanding and application of T regulatory cells in various medical contexts.

Collaborations

Some of his notable coworkers include Edgar George Engleman and Carl H June. Their collaborative efforts have contributed to the advancement of research in immunology and cell therapy.

Conclusion

Wayne R Godfrey's innovative work in the field of cord blood research exemplifies the impact of dedicated inventors in advancing medical science. His contributions continue to pave the way for new therapeutic possibilities.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]